BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 19242928)

  • 21. Decrease of telomeres and increase of interstitial telomeric sites in chromosomes of short-term cultured gastric carcinoma cells detected by fluorescence in situ hybridization.
    Kashima K; Nanashima A; Yasutake T; Sawai T; Tsuji T; Hidaka S; Akama F; Miyashita K; Tagawa Y; Nagayasu T
    Anticancer Res; 2006; 26(4B):2849-55. PubMed ID: 16886604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Array-comparative genomic hybridization of central chondrosarcoma: identification of ribosomal protein S6 and cyclin-dependent kinase 4 as candidate target genes for genomic aberrations.
    Rozeman LB; Szuhai K; Schrage YM; Rosenberg C; Tanke HJ; Taminiau AH; Cleton-Jansen AM; Bovée JV; Hogendoorn PC
    Cancer; 2006 Jul; 107(2):380-8. PubMed ID: 16779802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytogenetic analyses of hepatocellular carcinoma by in situ hybridization with a chromosome-specific DNA probe.
    Kimura H; Kagawa K; Deguchi T; Nakajima T; Kakusui M; Ohkawara T; Katagishi T; Okanoue T; Kashima K; Ashihara T
    Cancer; 1996 Jan; 77(2):271-7. PubMed ID: 8625234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors.
    Salas S; Chibon F; Noguchi T; Terrier P; Ranchere-Vince D; Lagarde P; Benard J; Forget S; Blanchard C; Dômont J; Bonvalot S; Guillou L; Leroux A; Mechine-Neuville A; Schöffski P; Laë M; Collin F; Verola O; Carbonnelle A; Vescovo L; Bui B; Brouste V; Sobol H; Aurias A; Coindre JM
    Genes Chromosomes Cancer; 2010 Jun; 49(6):560-8. PubMed ID: 20232483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship of DNA ploidy to chromosomal instability in primary human colorectal cancers.
    Miyazaki M; Furuya T; Shiraki A; Sato T; Oga A; Sasaki K
    Cancer Res; 1999 Oct; 59(20):5283-5. PubMed ID: 10537310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies.
    Takahashi S; Qian J; Brown JA; Alcaraz A; Bostwick DG; Lieber MM; Jenkins RB
    Cancer Res; 1994 Jul; 54(13):3574-9. PubMed ID: 8012984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aneuploidy in oncocytic lesions of the thyroid gland: diffuse accumulation of mitochondria within the cell is associated with trisomy 7 and progressive numerical chromosomal alterations.
    Dettori T; Frau DV; Lai ML; Mariotti S; Uccheddu A; Daniele GM; Tallini G; Faa G; Vanni R
    Genes Chromosomes Cancer; 2003 Sep; 38(1):22-31. PubMed ID: 12874783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic alterations of chromosome region 11p as predictive marker by array comparative genomic hybridization in lung adenocarcinoma patients.
    Sung JS; Park KH; Kim YH
    Cancer Genet Cytogenet; 2010 Apr; 198(1):27-34. PubMed ID: 20303011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression profiling and gene copy-number changes in malignant mesothelioma cell lines.
    Zanazzi C; Hersmus R; Veltman IM; Gillis AJ; van Drunen E; Beverloo HB; Hegmans JP; Verweij M; Lambrecht BN; Oosterhuis JW; Looijenga LH
    Genes Chromosomes Cancer; 2007 Oct; 46(10):895-908. PubMed ID: 17620293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristic pattern of genetic aberrations in ovarian granulosa cell tumors.
    Mayr D; Kaltz-Wittmer C; Arbogast S; Amann G; Aust DE; Diebold J
    Mod Pathol; 2002 Sep; 15(9):951-7. PubMed ID: 12218213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization.
    Kresse SH; Ohnstad HO; Paulsen EB; Bjerkehagen B; Szuhai K; Serra M; Schaefer KL; Myklebost O; Meza-Zepeda LA
    Genes Chromosomes Cancer; 2009 Aug; 48(8):679-93. PubMed ID: 19441093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No genomic aberrations in Langerhans cell histiocytosis as assessed by diverse molecular technologies.
    da Costa CE; Szuhai K; van Eijk R; Hoogeboom M; Sciot R; Mertens F; Björgvinsdóttir H; Debiec-Rychter M; de Krijger RR; Hogendoorn PC; Egeler RM; Annels NE
    Genes Chromosomes Cancer; 2009 Mar; 48(3):239-49. PubMed ID: 19051326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic profiling of myeloid sarcoma by array comparative genomic hybridization.
    Deeb G; Baer MR; Gaile DP; Sait SN; Barcos M; Wetzler M; Conroy JM; Nowak NJ; Cowell JK; Cheney RT
    Genes Chromosomes Cancer; 2005 Dec; 44(4):373-83. PubMed ID: 16080198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orbital rhabdomyosarcoma: relationship between DNA ploidy, p53, bcl-2, MDR-1 and Ki67 (MIB1) expression and clinical behavior.
    Staibano S; Franco R; Tranfa F; Mezza E; Lo Muzio L; Strianese D; Errico ME; Bufo P; Ferrara G; Somma P; Mansueto G; Greco I; Fiorillo A; Bonavolontà G; De Rosa G
    Anticancer Res; 2004; 24(1):249-57. PubMed ID: 15015604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The relationships among DNA ploidy type determined by laser scanning cytometry, the overexpression of p53 protein and the numerical aberrations of chromosome 7 in bladder cancer].
    Kawamura K; Ikeda R; Suzuki K
    Hinyokika Kiyo; 2000 Jun; 46(6):377-83. PubMed ID: 10934605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal heterogeneity in childhood myelodysplastic syndromes--challenge for the detection of chromosomal imbalances by array-CGH.
    Praulich I; Tauscher M; Göhring G; Glaser S; Hofmann W; Feurstein S; Flotho C; Lichter P; Niemeyer CM; Schlegelberger B; Steinemann D
    Genes Chromosomes Cancer; 2010 Oct; 49(10):885-900. PubMed ID: 20589934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical and biogenetic features of diffuse-type tenosynovial giant cell tumors: the potential roles of cyclin A, P53, and deletion of 15q in sarcomatous transformation.
    Huang HY; West RB; Tzeng CC; van de Rijn M; Wang JW; Chou SC; Huang WW; Eng HL; Lin CN; Yu SC; Wu JM; Lu CC; Li CF
    Clin Cancer Res; 2008 Oct; 14(19):6023-32. PubMed ID: 18829481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P53 expression as a prognostic marker in giant cell tumor of bone: a pilot study.
    Papanastassiou I; Ioannou M; Papagelopoulos PJ; Arealis G; Mihas C; Iakovidou I; Demertzis N
    Orthopedics; 2010 May; 33(5):. PubMed ID: 20506947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
    Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
    Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of DNA ploidy, histologic, and immunohistochemical findings with clinical outcome in inflammatory myofibroblastic tumors.
    Hussong JW; Brown M; Perkins SL; Dehner LP; Coffin CM
    Mod Pathol; 1999 Mar; 12(3):279-86. PubMed ID: 10102613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.